Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis

Area of Science:

• Environmental Toxicology
• Molecular Carcinogenesis
• Epigenetics

Background:

• Arsenic is a known human carcinogen, but its role in lung cancer development is not fully understood.
• Arsenic metabolism involves methylation, suggesting potential interference with DNA methylation processes (epigenetic carcinogenicity).

Purpose of the Study:

• To investigate if arsenic exposure induces DNA methylation changes leading to altered gene expression in lung cancer pathways.
• To identify specific genes and molecular networks involved in arsenic-induced lung cancer promotion and progression.

Main Methods:

• A549 human lung adenocarcinoma cells were exposed to varying concentrations of sodium arsenite for different durations.
• Whole-genome DNA methylation analysis was performed using NimbleGen promoter arrays.
• Whole-genome transcriptomic analysis was conducted using Affymetrix microarrays.
• Molecular interaction networks were constructed integrating DNA methylation, gene expression, and transcription factor data.

Main Results:

• Arsenic exposure modulated DNA methylation and gene expression in hundreds of genes in a dose- and time-dependent manner.
• A molecular interaction network of 216 genes was created, highlighting a tumor protein p53 (TP53) subnetwork.
• New genes with altered DNA methylation and expression were identified, including transcription factors that regulate lung cancer-associated genes.

Conclusions:

• Arsenic exposure can induce epigenetic alterations, specifically changes in DNA methylation and gene expression, contributing to lung cancer.
• The study identified key molecular players and networks, including TP53 interactions, involved in arsenic-induced lung carcinogenesis.
• Arsenic's modulation of transcription factors represents a significant mechanism in lung cancer promotion and progression.